1) Fasolo A, Capuzzo C, Fornea M, et al. Risk factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study. Cornea 2011;30:1328-35.
4) Inoue K, Amano S, Oshika T, Tsuru T. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand 2001;79:251-5.
5) Claesson M, Armitage WJ. Clinical outcome of repeat penetrating keratoplasty. Cornea 2013;32:1026-30.
6) Al-Mezaine H, Wagoner MD. King Khaled Eye Specialist Hospital Cornea Transplant Study Group. Repeat penetrating keratoplasty: indications, graft survival, and visual outcome. Br J Ophthalmol 2006;90:324-7.
7) Yamazoe K, Yamazoe K, Yamaguchi T, et al. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine. Cornea 2014;33:1157-63.
8) Park CY, Lee JK, Gore PK, et al. Keratoplasty in the United States: A 10-year review from 2005 through 2014. Ophthalmology 2015;122:2432-42.
9) Lee WB, Shtein RM, Kaufman SC, et al. Boston keratoprosthesis: outcomes and complications: a report by the American Academy of Ophthalmology. Ophthalmology 2015;122:1504-11.
10) Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 2014;121:2159-64.
11) Ahmad S, Mathews PM, Lindsley K, et al. Boston Type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure: a systematic review and meta-analysis. Ophthalmology 2016;123:165-77.
12) Hayashi R, Ishikawa Y, Sasamoto Y, et al. Co-ordinated ocular development from human iPS cells and recovery of corneal function. Nature 2016;531:376-80.
13) Choi SH, Lee YW, Kim HM, et al. Epidemiologic studies of keratoplasty in Korea. J Korean Ophthalmol Soc 2006;47:538-47.
14) Lee KM, Chung SK. Studies of patients maintaining clear cornea over 20 years following penetrating keratoplasty. J Korean Ophthalmol Soc 2009;50:19-26.
15) Jang JY, Woo JM, Yoon KC. Long-term results after three or more penetrating keratoplasties and risk factors for graft failure. J Korean Ophthalmol Soc 2011;52:1399-404.
16) Weisbrod DJ, Sit M, Naor J, Slomovic AR. Outcomes of repeat penetrating keratoplasty and risk factors for graft failure. Cornea 2003;22:429-34.
18) Abbas A, Khan B, Feroze AH, Hyman GF. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis. J Pak Med Assoc 2002;52:476-82.
19) Yalniz-Akkaya Z, Burcu Nurozler A, Yildiz E, et al. Repeat penetrating keratoplasty: indications and prognosis, 1995-2005. Eur J Ophthalmol 2009;19:362-8.
20) Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology 2010;117:1300-5.e7.
21) Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003;110:1396-402.
22) Giménez F, Suryawanshi A, Rouse BT. Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res 2013;33:1-9.
24) Zhang J, Wang S, He Y, et al. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization. Chem Biol Drug Des 2020;95:485-92.
25) Altenburger AE, Bachmann B, Seitz B, Cursiefen C. Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol 2012;250:1663-71.
28) John T, Foulks GN, John ME, et al. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 2002;109:351-60.
29) Chang YS, Huang FC, Tseng SH, et al. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 2007;26:123-9.
31) Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995;102:576-85.
32) Yu AL, Kaiser M, Schaumberger M, et al. Donor-related risk factors and preoperative recipient-related risk factors for graft failure. Cornea 2014;33:1149-56.
33) Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994;101:1536-47.
34) Brown SI, Bloomfield SE, Pearce DB. A follow-up report on transplantation of the alkali-burned cornea. Am J Ophthalmol 1974;77:538-42.
35) Le Q, Xu J, Deng SX. The diagnosis of limbal stem cell deficiency. Ocul Surf 2018;16:58-69.
36) Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002;109:1159-66.